Biotech

All Articles

Analysts explore Avidity's DMD succeed, exposing subtleties in information

.Avidity Biosciences impressed capitalists along with phase 1/2 data in Duchenne muscular dystrophy ...

Actinogen's cortisol blocker fails stage 2 anxiety study

.Actinogen Medical's cortisol blocker has actually skipped the main endpoint of a period 2 study in ...

Bivictrix determines going exclusive only method to take ADC into facility

.Antibody-drug conjugates (ADCs) have actually been at the center of numerous a billion-dollar biobu...

TPG leadings up funds to $580M for financial investments around lifestyle sciences

.Resource manager TPG, which has actually assisted biotechs such as Sionna Rehabs and Santa Clam Ana...

Merck stops stage 3 TIGIT trial in bronchi cancer for impossibility

.Merck &amp Co.'s TIGIT plan has suffered an additional problem. Months after shuttering a phase 3 c...

After a tough year, Exscientia folds up into Recursion

.After a year defined by pipeline cuts, the shift of its own chief executive officer as well as unem...

Cullinan, after $25M deal, restore bispecific to Port

.Cullinan Rehab was made an impression on sufficient along with Harbour BioMed's bispecific immune s...

A closer examine Intense Biotech's Brutal 15

.Within this full week's episode of "The Top Pipe," our company are actually diving right into Bruta...

Lilly deals with phase 2 breakdown of tau-targeting med

.The confetti is still flying coming from Eli Lilly's celebration commemorating the approval of Alzh...

Biogen CMO Maha Radhakrishnan participates in Sofinnova-- Chutes &amp Ladders

.Invite to this week's Chutes &amp Ladders, our summary of substantial management hirings, shootings...